Sr. Director - Business Development & Strategy

Eli Lilly Eli Lilly · Pharma · US: USA, United States +2 · Remote

Senior Director of Corporate Development at Eli Lilly, focusing on identifying and executing complex transactions for white space opportunities outside core therapeutic areas. Requires strong corporate development, transactional experience, and market agility to assess new markets and structure deals.

What you'd actually do

  1. Proactively identify ground-breaking opportunities outside Lilly's existing therapeutic areas, including those that could create entirely new areas of focus for the company.
  2. Build rapid, credible assessments of unfamiliar markets by synthesizing scientific, commercial, and financial signals into clear investment theses that can inform go/no-go decisions.
  3. Support all stages of transaction execution — from initial outreach through term sheet, due diligence, negotiation, and close
  4. Design creative deal structures that address the commercial, financial, and risk-sharing needs of both Lilly and its counterparties, including multi-therapeutic area and cross-functional transactions.
  5. Work closely with Search & Evaluation colleagues on the Corporate Development & BD Strategy team, as well as scientific and commercial partners across the broader organization and externally, to identify and access the right therapeutic area expertise for deals in areas of interest — ensuring every transaction is grounded in rigorous scientific and strategic evaluation.

Skills

Required

  • Bachelor's or advanced degree in a relevant field.
  • Minimum 5 years of experience in biopharmaceutical or biotech industries in roles spanning business development, investment banking, venture capital, private equity, management consulting, R&D, finance, or commercial strategy.
  • End-to-end experience across multiple transaction types and a history of successful closings.
  • Confident cross functional influencer who can also help to manage counterparty dynamics while protecting Lilly's long-term interests.
  • Ability to ramp quickly on new science, new markets, and new competitive landscapes — forming reliable, well-founded views without deep prior domain expertise.
  • Intellectually curious and comfortable operating at the frontier of Lilly's strategy.
  • Able to build credibility quickly with scientific, commercial, and finance team members.
  • Clear, compelling communicator who can make the complex simple — in writing, in presentations, and in real-time dialogue.
  • Self-starter with strong bias to action and exceptional organizational skills in a fast-paced environment.

Nice to have

  • Experience evaluating opportunities in therapeutic areas or technology platforms outside your primary expertise — and doing so with rigor and speed.
  • Fluency in commercial forecasting and quantitative market assessment methodologies.
  • History of creative deal structuring, including milestone-based, co-development, or platform licensing arrangements.

What the JD emphasized

  • Minimum 5 years of experience in biopharmaceutical or biotech industries in roles spanning business development, investment banking, venture capital, private equity, management consulting, R&D, finance, or commercial strategy.